Whole-organ tissue engineering: Decellularization and recellularization of three-dimensional matrix scaffolds

Annual Review of Biomedical Engineering

Volumn 13, Issue , 2011, Pages 27-53

  Badylak, Stephen F ^a,b   Taylor, Doris ^c   Uygun, Korkut ^d,e  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e SHRINERS HOSPITALS FOR CHILDREN   (United States)

Author keywords

Decellularization; Extracellular matrix; Organ engineering; Regenerative medicine; Three dimensional scaffold; Tissue engineering

Indexed keywords

DECELLULARIZATION; EXTRACELLULAR MATRICES; ORGAN ENGINEERING; REGENERATIVE MEDICINE; THREE-DIMENSIONAL SCAFFOLDS;

CELL CULTURE; CELL PROLIFERATION; ENGINEERING; THREE DIMENSIONAL; TISSUE;

SCAFFOLDS (BIOLOGY);

TISSUE SCAFFOLD;

ARTICLE; BIOREACTOR; CELL CULTURE; CELL TYPE; CELLULAR PARAMETERS; DECELLULARIZATION; EMBRYONIC STEM CELL; EXTRACELLULAR MATRIX; FETUS CELL; HEART; HUMAN; KIDNEY; LIVER; LUNG; NONHUMAN; OXYGEN TRANSPORT; PANCREAS; PLURIPOTENT STEM CELL; RECELLULARIZATION; TISSUE ENGINEERING; UMBILICAL CORD BLOOD;

AMNIOTIC FLUID; ANIMALS; BIOREACTORS; CELLS, CULTURED; EMBRYONIC STEM CELLS; EXTRACELLULAR MATRIX; FETAL BLOOD; HUMANS; INDUCED PLURIPOTENT STEM CELLS; ORGAN CULTURE TECHNIQUES; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

ANIMALIA;

EID: 79960351640     PISSN: 15239829     EISSN: 15454274     Source Type: Book Series    
DOI: 10.1146/annurev-bioeng-071910-124743     Document Type: Article

References (163)

1. United States Renal Data System (USRDS). 2009. http://www.usrds.org/
2. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, et al. 2010. Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 121:e46-e215
3. Heron M, Hoyert DL, Murphy SL, Xu J, Kochanek KD, Tejada-Vera B. 2009. Deaths: final data for 2006. Natl. Vital Stat. Rep. 57:1-134
4. Shin'oka T, Imai Y, Ikada Y. 2001. Transplantation of a tissue-engineered pulmonary artery. N. Engl. J. Med. 344:532-33
5. L'Heureux N,McAllister TN, de la Fuente LM. 2007. Tissue-engineered blood vessel for adult arterial revascularization. N. Engl. J. Med. 357:1451-53
6. Atala A, Bauer SB, Soker S, Yoo JJ, Retik AB. 2006. Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet 367:1241-46
7. Macchiarini P, Jungebluth P, Go T, Asnaghi MA, Rees LE, et al. 2008. Clinical transplantation of a tissue-engineered airway. Lancet 372:2023-30
8. Macchiarini P,Walles T, Biancosino C, Mertsching H. 2004. First human transplantation of a bioengineered airway tissue. J. Thorac. Cardiovasc. Surg. 128:638-41 (Pubitemid 39278409)
9. Ott HC, Matthiesen TS, Goh SK, Black LD, Kren SM, et al. 2008. Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat. Med. 14:213-21 (Pubitemid 351214548)
10. Uygun BE, Soto-Gutierrez A, Yagi H, Izamis ML, Guzzardi MA, et al. 2010. Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix. Nat. Med. 16:814-20
11. Petersen TH, Calle EA, Zhao L, Lee EJ, Gui L, et al. 2010. Tissue-engineered lungs for in vivo implantation. Science 329:538-41
12. Price AP, England KA, Matson AM, Blazar BR, Panoskaltsis-Mortari A. 2010. Development of a decellularized lung bioreactor system for bioengineering the lung: the matrix reloaded. Tissue Eng. Part A 16:2581-91
13. Ott HC, Clippinger B, Conrad C, Schuetz C, Pomerantseva I, et al. 2010. Regeneration and orthotopic transplantation of a bioartificial lung. Nat. Med. 16:927-33
14. Cortiella J, Niles J, Cantu A, Brettler A, Pham A, et al. 2010. Influence of acellular natural lung matrix on murine embryonic stem cell differentiation and tissue formation. Tissue Eng. Part A 16:2565-80
15. Niklason LE, Gao J, AbbottWM, Hirschi KK, Houser S, et al. 1999. Functional arteries grown in vitro. Science 284:489-93 (Pubitemid 29289622)
16. Chen RN, Ho HO,Tsai YT, SheuMT. 2004. Process development of an acellular dermal matrix (ADM) for biomedical applications. Biomaterials 25:2679-86
17. Badylak SF, Lantz GC, Coffey A, Geddes LA. 1989. Small intestinal submucosa as a large diameter vascular graft in the dog. J. Surg. Res. 47:74-80 (Pubitemid 19183414)
18. Badylak SF, Tullius R, Kokini K, Shelbourne KD, Klootwyk T, et al. 1995. The use of xenogeneic small intestinal submucosa as a biomaterial for Achilles tendon repair in a dog model. J. Biomed. Mater. Res. 29:977-85
19. Kropp BP, Eppley BL, Prevel CD, Rippy MK, Harruff RC, et al. 1995. Experimental assessment of small intestinal submucosa as a bladder wall substitute. Urology 46:396-400
20. Chen F, Yoo JJ, Atala A. 1999. Acellular collagen matrix as a possible "off the shelf " biomaterial for urethral repair. Urology 54:407-10 (Pubitemid 29407010)
21. Freytes DO, Badylak SF,Webster TJ,Geddes LA, Rundell AE. 2004. Biaxial strength of multilaminated extracellular matrix scaffolds. Biomaterials 25:2353-61
22. Gilbert TW, Stolz DB, Biancaniello F, Simmons-Byrd A, Badylak SF. 2005. Production and characterization of ECM powder: implications for tissue engineering applications. Biomaterials 26:1431-35
23. Conklin BS, Richter ER, Kreutziger KL, Zhong DS, Chen C. 2002. Development and evaluation of a novel decellularized vascular xenograft. Med. Eng. Phys. 24:173-83 (Pubitemid 34327597)
24. Dahl SL, Koh J, Prabhakar V,Niklason LE. 2003. Decellularized native and engineered arterial scaffolds for transplantation. Cell Transplant. 12:659-66 (Pubitemid 37204423)
25. Schmidt CE, Baier JM. 2000. Acellular vascular tissues: natural biomaterials for tissue repair and tissue engineering. Biomaterials 21:2215-31
26. Uchimura E, Sawa Y, Taketani S, Yamanaka Y, Hara M, et al. 2003. Novel method of preparing acellular cardiovascular grafts by decellularization with poly(ethylene glycol). J. Biomed. Mater. Res. A 67:834-37 (Pubitemid 37521557)
27. Bader A, Schilling T, Teebken OE, Brandes G, Herden T, et al. 1998. Tissue engineering of heart valves-human endothelial cell seeding of detergent acellularized porcine valves. Eur. J. Cardiothorac. Surg. 14:279-84 (Pubitemid 28417083)
28. Booth C, Korossis SA, Wilcox HE, Watterson KG, Kearney JN, et al. 2002. Tissue engineering of cardiac valve prostheses I: development and histological characterization of an acellular porcine scaffold. J. Heart Valve Dis. 11:457-62 (Pubitemid 34812114)
29. Grauss RW,Hazekamp MG,Oppenhuizen F, van Munsteren CJ, Gittenberger-deGroot AC,DeRuiter MC. 2005. Histological evaluation of decellularised porcine aortic valves:matrix changes due to different decellularisation methods. Eur. J. Cardiothorac. Surg. 27:566-71 (Pubitemid 40409725)
30. Kasimir MT, Rieder E, Seebacher G, Silberhumer G, Wolner E, et al. 2003. Comparison of different decellularization procedures of porcine heart valves. Int. J. Artif. Organs 26:421-27 (Pubitemid 36826683)
31. Korossis SA, Booth C, Wilcox HE, Watterson KG, Kearney JN, et al. 2002. Tissue engineering of cardiac valve prostheses II: biomechanical characterization of decellularized porcine aortic heart valves. J. Heart Valve Dis. 11:463-71 (Pubitemid 34812115)
32. Rieder E, KasimirMT, Silberhumer G, Seebacher G, Wolner E, et al. 2004. Decellularization protocols of porcine heart valves differ importantly in efficiency of cell removal and susceptibility of the matrix to recellularization with human vascular cells. J. Thorac. Cardiovasc. Surg. 127:399-405 (Pubitemid 38176643)
33. Schenke-Layland K, Vasilevski O, Opitz F, Konig K, Riemann I, et al. 2003. Impact of decellularization of xenogeneic tissue on extracellular matrix integrity for tissue engineering of heart valves. J. Struct. Biol. 143:201-8 (Pubitemid 37297860)
34. Bissell MJ, Aggeler J. 1987. Dynamic reciprocity: How do extracellular matrix and hormones direct gene expression? Prog. Clin. Biol. Res. 249:251-62
35. Sellaro TL, Ranade A, FaulkDM, McCabe GP,Dorko K, et al. 2010. Maintenance of human hepatocyte function in vitro by liver-derived extracellular matrix gels. Tissue Eng. Part A 16:1075-82
36. Lin P, Chan WC, Badylak SF, Bhatia SN. 2004. Assessing porcine liver-derived biomatrix for hepatic tissue engineering. Tissue Eng. 10:1046-53
37. Sellaro TL, Ravindra AK, Stolz DB, Badylak SF. 2007. Maintenance of hepatic sinusoidal endothelial cell phenotype in vitro using organ-specific extracellular matrix scaffolds. Tissue Eng. 13:2301-10
38. Lin YM, Zhang A, Rippon HJ, Bismarck A, Bishop AE. 2010. Tissue engineering of lung: the effect of extracellular matrix on the differentiation of embryonic stem cells to pneumocytes. Tissue Eng. Part A 16:1515-26
39. Brown B, Lindberg K, Reing J, Stolz DB, Badylak SF. 2006. The basement membrane component of biologic scaffolds derived from extracellular matrix. Tissue Eng. 12:519-26 (Pubitemid 43673457)
40. SacksMS, GloecknerDC. 1999. Quantification of the fiber architecture and biaxial mechanical behavior of porcine intestinal submucosa. J. Biomed. Mater. Res. 46:1-10 (Pubitemid 29233175)
41. Gong J, SagivO, Cai H, Tsang SH, Del Priore LV. 2008. Effects of extracellular matrix and neighboring cells on induction of human embryonic stem cells into retinal or retinal pigment epithelial progenitors. Exp. Eye Res. 86:957-65
42. Hosokawa T, Betsuyaku T, Nishimura M, Furuyama A, Katagiri K, Mochitate K. 2007. Differentiation of tracheal basal cells to ciliated cells and tissue reconstruction on the synthesized basement membrane substratum in vitro. Connect. Tissue Res. 48:9-18 (Pubitemid 46371973)
43. Hosokawa T, BetsuyakuT,Odajima N, Suzuki M, MochitateK, et al. 2008. Role of basement membrane in EMMPRIN/CD147 induction in rat tracheal epithelial cells. Biochem. Biophys. Res. Commun. 368:426-32
44. Voytik-Harbin SL, Brightman AO, Kraine MR, Waisner B, Badylak SF. 1997. Identification of extractable growth factors from small intestinal submucosa. J. Cell Biochem. 67:478-91 (Pubitemid 27508401)
45. Hodde JP, Record RD, Liang HA, Badylak SF. 2001. Vascular endothelial growth factor in porcinederived extracellular matrix. Endothelium 8:11-24 (Pubitemid 32454574)
46. Hodde JP, Record R, Tullius R, Badylak SF. 2002. Fibronectin peptides mediate HMEC adhesion to porcine-derived extracellular matrix. Biomaterials 23:1841-48
47. BrennanEP, Reing J,ChewD,Myers-Irvin JM,YoungEJ, Badylak SF. 2006. Antibacterial activitywithin degradation products of biological scaffolds composed of extracellular matrix. Tissue Eng. 12:2949-55
48. Sarikaya A, Record R, Wu CC, Tullius B, Badylak S, LadischM. 2002. Antimicrobial activity associated with extracellular matrices. Tissue Eng. 8:63-71 (Pubitemid 34194665)
49. Taylor DA. 2009. From stem cells and cadaveric matrix to engineered organs. Curr. Opin. Biotechnol. 20:598-605
50. Wainwright JM, Czajka CA, Patel UB, Freytes DO, Tobita K, et al. 2010. Preparation of cardiac extracellular matrix from an intact porcine heart. Tissue Eng. Part C Methods 16:525-32
51. ErdagG,Morgan JR. 2004. Allogeneic versus xenogeneic immune reaction to bioengineered skin grafts. Cell Transplant. 13:701-12 (Pubitemid 40116925)
52. Gock H, Murray-Segal L, Salvaris E, Cowan P, D'Apice AJ. 2004. Allogeneic sensitization is more effective than xenogeneic sensitization in eliciting Gal-mediated skin graft rejection. Transplantation 77:751-53 (Pubitemid 38366983)
53. Ross JR, Kirk AD, Ibrahim SE, Howell DN, Baldwin WM 3rd, Sanfilippo FP. 1993. Characterization of human anti-porcine "natural antibodies" recovered from ex vivo perfused hearts-predominance of IgM and IgG2. Transplantation 55:1144-50
54. BernardMP, ChuML, Myers JC, Ramirez F,Eikenberry EF, Prockop DJ. 1983. Nucleotide sequences of complementary deoxyribonucleic acids for the pro alpha 1 chain of human type I procollagen. Statistical evaluation of structures that are conserved during evolution. Biochemistry 22:5213-23
55. Bernard MP, Myers JC, Chu ML, Ramirez F, Eikenberry EF, Prockop DJ. 1983. Structure of a cDNA for the pro alpha 2 chain of human type I procollagen. Comparison with chick cDNA for pro alpha 2(I) identifies structurally conserved features of the protein and the gene. Biochemistry 22:1139-45
56. Constantinou CD, Jimenez SA. 1991. Structure of cDNAs encoding the triple-helical domain of murine alpha 2 (VI) collagen chain and comparison to human and chick homologues. Use of polymerase chain reaction and partially degenerate oligonucleotide for generation of novel cDNA clones. Matrix 11:1-9
57. Exposito JY, D'AlessioM, Solursh M, Ramirez F. 1992. Sea urchin collagen evolutionarily homologous to vertebrate pro-alpha 2(I) collagen. J. Biol. Chem. 267:15559-62
58. McPherson TB, Liang H, Record RD, Badylak SF. 2000. Galalpha(1,3)Gal epitope in porcine small intestinal submucosa. Tissue Eng. 6:233-39 (Pubitemid 30419206)
59. Raeder RH, Badylak SF, Sheehan C, Kallakury B, Metzger DW. 2002. Natural anti-galactose alpha1,3 galactose antibodies delay, but do not prevent the acceptance of extracellular matrix xenografts. Transplant. Immunol. 10:15-24 (Pubitemid 34863320)
60. Daly K, Stewart-Akers A, Hara H, Ezzelarab M, Long C, et al. 2009. Effect of the alphaGal epitope on the response to small intestinal submucosa extracellular matrix in a nonhuman primate model. Tissue Eng. Part A 15:3877-88
61. Badylak SF, Valentin JE, Ravindra AK, McCabe GP, Stewart-Akers AM. 2008. Macrophage phenotype as a determinant of biologic scaffold remodeling. Tissue Eng. Part A 14:1835-42
62. Derwin KA, Baker AR, Spragg RK, Leigh DR, Iannotti JP. 2006. Commercial extracellular matrix scaffolds for rotator cuff tendon repair. Biomechanical, biochemical, and cellular properties. J. Bone Joint Surg. Am. 88:2665-72
63. Gilbert TW, Freund JM, Badylak SF. 2009. Quantification of DNA in biologic scaffold materials. J. Surg. Res. 152:135-39
64. Halloran PF. 2004. Immunosuppressive drugs for kidney transplantation. N. Engl. J. Med. 351:2715-29
65. Geron Corp. 2010. Safety study of GRNOPC1 in spinal cord injury. http://clinicaltrials.gov/show/NCT01217008
66. Marot D, KnezevicM, Novakovic GV. 2010. Bone tissue engineering with human stem cells. Stem. Cell Res. Ther. 1:10
67. Kofidis T, de Bruin JL, Hoyt G, Ho Y, Tanaka M, et al. 2005. Myocardial restoration with embryonic stem cell bioartificial tissue transplantation. J. Heart Lung Transplant. 24:737-44 (Pubitemid 40798258)
68. Nussbaum J,Minami E, Laflamme MA, Virag JA, Ware CB, et al. 2007. Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response. FASEB J. 21:1345-57
69. Lees JG, Lim SA, Croll T,Williams G, Lui S, et al. 2007. Transplantation of 3D scaffolds seeded with human embryonic stem cells: biological features of surrogate tissue and teratoma-forming potential. Regen. Med. 2:289-300 (Pubitemid 46845887)
70. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, et al. 2007. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861-72 (Pubitemid 350138099)
71. Zhang Y, ShenW, Sun B, Lv C, Dou Z. 2011. Plasticity of marrow mesenchymal stem cells from human first-trimester fetus: from single-cell clone to neuronal differentiation. Cell. Reprogram. 13(1):57-64
72. Zhang ZY, Teoh SH, Teo EY, Khoon Chong MS, Shin CW, et al. 2010. A comparison of bioreactors for culture of fetal mesenchymal stem cells for bone tissue engineering. Biomaterials 31:8684-95
73. Oertel M, Shafritz DA. 2008. Stem cells, cell transplantation and liver repopulation. Biochim. Biophys. Acta 1782:61-74
74. Decembrini S, Cananzi M, Gualdoni S, Battersby A, Allen N, et al. 2011. Comparative analysis of the retinal potential of embryonic stem cells and amniotic fluid-derived stem cells. Stem Cells Dev. 20(5):851-63
75. Galende E, Karakikes I, Edelmann L, Desnick RJ, Kerenyi T, et al. 2010. Amniotic fluid cells are more efficiently reprogrammed to pluripotency than adult cells. Cell Reprogram. 12:117-25
76. Phermthai T, Odglun Y, Julavijitphong S, Titapant V, Chuenwattana P, et al. 2010. A novel method to derive amniotic fluid stem cells for therapeutic purposes. BMC Cell Biol. 11:79
77. Aboushwareb T, Atala A. 2008. Stem cells in urology. Nat. Clin. Pract. Urol. 5:621-31
78. Antonucci I, Pantalone A, De Amicis D, D'Onofrio S, Stuppia L, et al. 2009. Human amniotic fluid stem cells culture onto titanium screws: a new perspective for bone engineering. J. Biol. Regul. Homeost. Agents 23:277-9
79. Peister A, Deutsch ER, Kolambkar Y, Hutmacher DW, Guldberg RE. 2009. Amniotic fluid stem cells produce robust mineral deposits on biodegradable scaffolds. Tissue Eng. Part A 15:3129-38
80. Roomans GM. 2010. Tissue engineering and the use of stem/progenitor cells for airway epithelium repair. Eur. Cell Mater. 19:284-99
81. Cananzi M, Atala A, De Coppi P. 2009. Stem cells derived from amniotic fluid: new potentials in regenerative medicine. Reprod. Biomed. Online 18(Suppl. 1):17-27
82. Takahashi K, Yamanaka S. 2006. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663-76 (Pubitemid 44233629)
83. Wernig M, Meissner A, Foreman R, Brambrink T, Ku M, et al. 2007. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448:318-24 (Pubitemid 47080337)
84. Maherali N, Sridharan R, Xie W, Utikal J, Eminli S, et al. 2007. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem. Cell 1:55-70
85. Vogel G, Holden C. 2007. Developmental biology. Field leaps forward with new stem cell advances. Science 318:1224-25
86. Lengner CJ. 2010. iPS cell technology in regenerative medicine. Ann. NY Acad. Sci. 1192:38-44
87. Kusuma S, Gerecht S. 2010. Engineering blood vessels using stem cells: innovative approaches to treat vascular disorders. Expert Rev. Cardiovasc. Ther. 8:1433-45
88. Xu D, Wang F, Gu H, Wang J, Guo Q, et al. 2010. Hybrid cells differentiate to hepatic lineage cells and repair oxidative damage. Cell Mol. Biol. Lett. 15:451-72
89. Sawada R, Ito T, Tsuchiya T. 2007. Safety evaluation of tissue engineered medical devices using normal human mesenchymal stem cells. Yakugaku Zasshi 127:851-56 (In Japanese) (Pubitemid 46684733)
90. de Peppo GM, Sjovall P, Lenneras M, Strehl R, Hyllner J, et al. 2010. Osteogenic potential of human mesenchymal stem cells and human embryonic stem cell-derived mesodermal progenitors: a tissue engineering perspective. Tissue Eng. Part A 16:3413-26
91. Chanda D, Kumar S, Ponnazhagan S. 2010. Therapeutic potential of adult bone marrow-derived mesenchymal stem cells in diseases of the skeleton. J. Cell Biochem. 111:249-57
92. Petersen BE, Bowen WC, Patrene KD,MarsWM, Sullivan AK, et al. 1999. Bone marrow as a potential source of hepatic oval cells. Science 284:1168-70
93. Caimi PF, Reese J, Lee Z, Lazarus HM. 2010. Emerging therapeutic approaches for multipotent mesenchymal stromal cells. Curr. Opin. Hematol. 17:505-13
94. Grompe M. 2005. Bone marrow-derived hepatocytes. Novartis Found. Symp. 265:20-27; discussion 28-34, 92-97
95. Alison MR. 2005. Liver stem cells: implications for hepatocarcinogenesis. Stem Cell Rev. 1:253-60 (Pubitemid 41737102)
96. Krause DS. 2008. Bone marrow-derived cells and stem cells in lung repair. Proc. Am. Thorac. Soc. 5:323-27 (Pubitemid 351520678)
97. Jezierska-Wozniak K, Nosarzewska D, Tutas A, Mikolajczyk A, Oklinski M, Jurkowski MK. 2010. Use of adipose tissue as a source of mesenchymal stem cells. Postepy Hig. Med. Dosw. 64:326-32
98. Li Y, Pan H, Huard J. 2010. Isolating stem cells from soft musculoskeletal tissues. J. Vis. Exp. doi: 10.3791/2011
99. Parmacek MS. 2006. Cardiac stem cells and progenitors: developmental biology and therapeutic challenges. Trans. Am. Clin. Climatol. Assoc. 117:239-55; discussion 55-56
100. Obokata H, Kojima K, Westerman K, Yamato M, Okano T, et al. 2011. The potential of stem cells in adult tissues representative of the three germ layers. Tissue Eng. Part A. 17:607-15
101. Quirici N, Scavullo C, de Girolamo L, Lopa S, Arrigoni E, et al. 2010. Anti-L-NGFR and-CD34 monoclonal antibodies identify multipotent mesenchymal stem cells in human adipose tissue. Stem. Cells Dev. 19:915-25
102. Ringe J, Leinhase I, Stich S, Loch A,Neumann K, et al. 2008. Human mastoid periosteum-derived stem cells: promising candidates for skeletal tissue engineering. J. Tissue Eng. Regener. Med. 2:136-46
103. Evseenko D, Zhu Y, Schenke-Layland K, Kuo J, Latour B, et al. 2010. Mapping the first stages of mesoderm commitment during differentiation of human embryonic stem cells. Proc. Natl. Acad. Sci. USA 107:13742-47
104. Prasad VK, Kurtzberg J. 2010. Transplant outcomes in mucopolysaccharidoses. Semin. Hematol. 47:59-69
105. Doan PL, Chao NJ. 2010. Advances in cord blood transplants in adults. F1000 Med. Rep. 2:12; doi: 10.3410/M2-12
106. Zaibak F, Bello P, Kozlovski J, Crombie D, Ang H, et al. 2009. Unrestricted somatic stem cells from human umbilical cord blood grow in serum-free medium as spheres. BMC Biotechnol. 9:101
107. Gyurkocza B, Rezvani A, Storb RF. 2010. Allogeneic hematopoietic cell transplantation: the state of the art. Expert Rev. Hematol. 3:285-99
108. Bonner-Weir S, Sharma A. 2002. Pancreatic stem cells. J. Pathol. 197:519-26
109. Bader A,Macchiarini P. 2010. Moving towards in situ tracheal regeneration: the bionic tissue engineered transplantation approach. J. Cell Mol. Med. 14:1877-89
110. Morin O, Normand C. 1986. Long-term maintenance of hepatocyte functional activity in coculture: requirements for sinusoidal endothelial cells and dexamethasone. J. Cell Physiol. 129:103-10 (Pubitemid 17178532)
111. Brutsaert DL. 2003. Cardiac endothelial-myocardial signaling: its role in cardiac growth, contractile performance, and rhythmicity. Physiol. Rev. 83:59-115 (Pubitemid 36459878)
112. Hermanns MI,Unger RE, Kehe K, Peters K, Kirkpatrick CJ. 2004. Lung epithelial cell lines in coculture with human pulmonary microvascular endothelial cells: development of an alveolo-capillary barrier in vitro. Lab. Investig. 84:736-52 (Pubitemid 38715474)
113. Shen Q, Goderie SK, Jin L, Karanth N, Sun Y, et al. 2004. Endothelial cells stimulate self-renewal and expand neurogenesis of neural stem cells. Science 304:1338-40
114. Vunjak-Novakovic G, Tandon N, Godier A, Maidhof R, Marsano A, et al. 2010. Challenges in cardiac tissue engineering. Tissue Eng. Part B Rev. 16:169-87
115. Nahmias Y, Berthiaume F, YarmushML. 2007. Integration of technologies for hepatic tissue engineering. Adv. Biochem. Eng. Biotechnol. 103:309-29
116. Lichtenberg A, Tudorache I, Cebotari S, Suprunov M, Tudorache G, et al. 2006. Preclinical testing of tissue-engineered heart valves re-endothelialized under simulated physiological conditions. Circulation 114:I559-65 (Pubitemid 44297208)
117. KasimirMT, Weigel G, Sharma J, Rieder E, Seebacher G, et al. 2005. The decellularized porcine heart valve matrix in tissue engineering: platelet adhesion and activation. Thromb. Haemost. 94:562-67 (Pubitemid 41300853)
118. LovettM, Lee K, Edwards A, Kaplan DL. 2009. Vascularization strategies for tissue engineering. Tissue Eng. Part B Rev. 15:353-70
119. Menon NG, Rodriguez ED, Byrnes CK, Girotto JA, Goldberg NH, Silverman RP. 2003. Revascularization of human acellular dermis in full-thickness abdominal wall reconstruction in the rabbit model. Ann. Plastic Surg. 50:523-27 (Pubitemid 36534926)
120. Schechner JS, Crane SK, Wang F, Szeglin AM, Tellides G, et al. 2003. Engraftment of a vascularized human skin equivalent. FASEB J. 17:2250-56
121. Bhatia SN, Balis UJ, YarmushML, TonerM. 1998. Microfabrication of hepatocyte/fibroblast cocultures: role of homotypic cell interactions. Biotechnol. Prog. 14:378-87 (Pubitemid 28278818)
122. Jindal R, Nahmias Y, Tilles AW, Berthiaume F, Yarmush ML. 2009. Amino acid-mediated heterotypic interaction governs performance of a hepatic tissue model. FASEB J. 23:2288-98
123. Kamkin A, Kiseleva I, IsenbergG. 2003. Activation and inactivation of a nonselective cation conductance by local mechanical deformation of acutely isolated cardiac fibroblasts. Cardiovasc. Res. 57:793-803 (Pubitemid 36254873)
124. Kamkin A, Kiseleva I, Lozinsky I, Scholz H. 2005. Electrical interaction of mechanosensitive fibroblasts and myocytes in the heart. Basic Res. Cardiol. 100:337-45 (Pubitemid 40974084)
125. Aschheim K. 2006. Anthony Atala. Nat. Biotechnol. 24:1311-11
126. Sussman NL, Kelly JH. 1993. Artificial liver: a forthcoming attraction. Hepatology 17:1163-64
127. Arkadopoulos N, Lilja H, Suh KS, Demetriou AA, Rozga J. 1998. Intrasplenic transplantation of allogeneic hepatocytes prolongs survival in anhepatic rats. Hepatology 28:1365-70
128. Kobayashi N, Miyazaki M, Fukaya K, Inoue Y, Sakaguchi M, et al. 2000. Transplantation of highly differentiated immortalized human hepatocytes to treat acute liver failure. Transplantation 69:202-7 (Pubitemid 30075275)
129. Bilir BM, Guinette D, Karrer F, Kumpe DA, Krysl J, et al. 2000. Hepatocyte transplantation in acute liver failure. Liver Transplant. 6:32-40 (Pubitemid 30123365)
130. Deutsch M, Meinhart J, Vesely M, Fischlein T, Groscurth P, et al. 1997. In vitro endothelialization of expanded polytetrafluoroethylene grafts: a clinical case report after 41 months of implantation. J. Vasc. Surg. 25:757-63 (Pubitemid 27190944)
131. Kulig KM, Vacanti JR. 2004. Hepatic tissue engineering. Transplant. Immunol. 12:303-10 (Pubitemid 38639725)
132. Ratcliffe A, Niklason LE. 2002. Bioreactors and bioprocessing for tissue engineering. In Reparative Medicine: Growing Tissues and Organs, ed. JD Sipe, CA Kelley, LA McNicol, pp. 210-15. New York: NY Acad. Sci. (Pubitemid 34727343)
133. Martin I, Smith T,Wendt D. 2009. Bioreactor-based roadmap for the translation of tissue engineering strategies into clinical products. Trends Biotechnol. 27:495-502
134. Martin I, Wendt D, Heberer M. 2004. The role of bioreactors in tissue engineering. Trends Biotechnol. 22:80-86 (Pubitemid 38130175)
135. Carrel A, Lindbergh CA. 1935. The culture of whole organs. Science 81:621-23
136. Lee CY, Mangino MJ. 2009. Preservation methods for kidney and liver. Organogenesis 5:105-12
137. Feng S. 2010. Donor intervention and organ preservation:Where is the science and what are the obstacles? Am. J. Transplant. 10:1155-62
138. Cobert ML,West LM, Jessen ME. 2008. Machine perfusion for cardiac allograft preservation. Current Opin. Organ Transplant. 13:526-30
139. Cypel M, Yeung JC, Hirayama S, Rubacha M, Fischer S, et al. 2008. Technique for prolonged normothermic ex vivo lung perfusion. J. Heart Lung Transplant. 27:1319-25
140. Brockmann J, Reddy S, Coussios C, Pigott D, Guirriero D, et al. 2009. Normothermic perfusion: a new paradigm for organ preservation. Ann. Surg. 250:1-6
141. Elaut G, Henkens T, Papeleu P, Snykers S, Vinken M, et al. 2006. Molecular mechanisms underlying the dedifferentiation process of isolated hepatocytes and their cultures. Curr. Drug Metab. 7:629-60
142. Brasile L, Stubenitsky BM, Booster MH, Lindell S, Araneda D, et al. 2002. Overcoming severe renal ischemia: the role of ex vivo warm perfusion. Transplantation 73:897-901 (Pubitemid 34252351)
143. Park J, Li Y, Berthiaume F, TonerM, Yarmush ML, Tilles AW. 2008. Radial flow hepatocyte bioreactor using stacked microfabricated grooved substrates. Biotechnol. Bioeng. 99:455-67 (Pubitemid 351158292)
144. Tolboom H, Pouw R, Uygun K, Tanimura Y, Izamis ML, et al. 2007. A model for normothermic preservation of the rat liver. Tissue Eng. 13:2143-51
145. Chan C, Berthiaume F, Lee K, Yarmush ML. 2003. Metabolic flux analysis of hepatocyte function in hormone-and amino acid-supplemented plasma. Metab. Eng. 5:1-15 (Pubitemid 36599676)
146. Badylak SE. 2002. The extracellular matrix as a scaffold for tissue reconstruction. Semin. Cell Dev. Biol. 13:377-83
147. Yamada T, Yang JJ, Ricchiuti NV, Seraydarian MW. 1985. Oxygen consumption of mammalian myocardial cells in culture: measurements in beating cells attached to the substrate of the culture dish. Anal. Biochem. 145:302-7 (Pubitemid 15100959)
148. Rotem A,Toner M, Tompkins RG, Yarmush ML. 1992. Oxygen uptake rates in cultured rat hepatocytes. Biotechnol. Bioeng. 40:1286-91
149. Nahmias Y, Kramvis Y, Barbe L, Casali M, Berthiaume F, Yarmush ML. 2006. A novel formulation of oxygen-carrying matrix enhances liver-specific function of cultured hepatocytes. FASEB J. 20:2531-33
150. Qiu Y, Hearse DJ. 1992. Comparison of ischemic vulnerability and responsiveness to cardioplegic protection in crystalloid-perfused versus blood-perfused hearts. J. Thorac. Cardiovasc. Surg. 103:960-68
151. Vohra HA, Whistance R,Modi A, Ohri SK. 2009. The inflammatory response to miniaturised extracorporeal circulation: a review of the literature. Mediat. Inflamm. 2009:707042; doi:10.1155/2009/707042
152. Bursac N, Loo Y, Leong K, Tung L. 2007. Novel anisotropic engineered cardiac tissues: studies of electrical propagation. Biochem. Biophys. Res. Commun. 361:847-53 (Pubitemid 47259017)
153. Radisic M, Fast VG, Sharifov OF, Iyer RK, Park H, Vunjak-Novakovic G. 2009. Optical mapping of impulse propagation in engineered cardiac tissue. Tissue Eng. Part A 15:851-60
154. Lysaght MJ, Hazlehurst AL. 2004. Tissue engineering: the end of the beginning. Tissue Eng. 10:309-20 (Pubitemid 38199385)
155. McAllister TN, Dusserre N, Maruszewski M, L'Heureux N. 2008. Cell-based therapeutics from an economic perspective: primed for a commercial success or a research sinkhole? Regenerat. Med. 3:925-37
156. van der Veen VC, van der Wal MB, van Leeuwen MC, Ulrich MM, Middelkoop E. 2009. Biological background of dermal substitutes. Burns 36:305-21
157. Bottcher-Haberzeth S, BiedermannT, Reichmann E. 2010. Tissue engineering of skin. Burns 36:450-60
158. Laschke MW, Vollmar B, Menger MD. 2009. Inosculation: connecting the life-sustaining pipelines. Tissue Eng. Part B Rev. 15:455-65
159. Strom SC, Fisher RA, ThompsonMT, Sanyal AJ, Cole PE, et al. 1997. Hepatocyte transplantation as a bridge to orthotopic liver transplantation in terminal liver failure. Transplantation 63:559-69 (Pubitemid 27102626)
160. Shapiro AMJ, Lakey JRT, Ryan EA, Korbutt GS, Toth E, et al. 2000. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N. Engl. J. Med. 343:230-38 (Pubitemid 30490390)
161. Badylak SF. 2004. Xenogeneic extracellular matrix as a scaffold for tissue reconstruction. Transplant. Immunol. 12:367-77 (Pubitemid 38639730)
162. Safar P. 1988. Clinical death symposium. Crit. Care Med. 16:919-20
163. Abt PL, Desai NM, Crawford MD, Forman LM, Markmann JW, et al. 2004. Survival following liver transplantation from non-heart-beating donors. Ann. Surg. 239:87-92 (Pubitemid 38176377)